Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses

9Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

Abstract: Outcomes of COrona VIrus Disease-19 (COVID-19) in patients with rheumatic diseases (RDs) reported in various studies are heterogenous owing to the influence of age and comorbidities which have a significant bearing on the infection risk, severity, morbidity, and mortality. Diabetes mellitus (DM) and RDs are closely linked with underlying pathobiology and treatment of RDs affecting the risk for DM as well as the glycemic control. Hence, we undertook this narrative review to study the influence of DM on outcomes of COVID-19 in patients with RDs. Additionally, aspects of patient attitudes and immune response to COVID-19 vaccination were also studied. The databases of MEDLINE/PubMed, Scopus, and Directory of Open Access Journals (DOAJ) were searched for relevant articles. Studies from mixed cohorts revealed insufficient data to comment on the influence of DM on the risk of infection, while most studies showed twice the odds for hospitalization and mortality with DM. Specific cohorts of rheumatoid arthritis and systemic lupus erythematosus revealed a similar association. Poor health was noted in patients with spondyloarthritis and DM during the pandemic. The presence of DM did not affect patient attitudes towards vaccination and did not predispose to additional vaccine-related adverse effects. Immune response to inactivated vaccines was reduced but mRNA vaccines were maintained in patients with DM. Detailed assessment of DM with its duration, end-organ damage, and glycemic control along with a focused association of DM with various aspects of COVID-19 like risk, hospitalization, severity, mortality, post-COVID sequelae, immune response to infection, and vaccination are needed in the future.Key Points• Diabetes mellitus is associated with the severity of infection, COVID-19-related hospitalization, and mortality in rheumatic diseases across most studies but studies analyzing its specific role are lacking.• Poor outcomes of COVID-19 in RA and poor health in spondyloarthritis are strongly associated with diabetes mellitus.• Diabetes mellitus may negatively influence the humoral response to inactivated vaccines but does not seem to affect the immune responses to mRNA vaccines.• Diabetes mellitus does not influence the attitude towards vaccination or deviation from the prescribed medications during the pandemic.

References Powered by Scopus

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

20064Citations
N/AReaders
Get full text

Factors associated with COVID-19-related death using OpenSAFELY

4425Citations
N/AReaders
Get full text

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review

3661Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs

10Citations
N/AReaders
Get full text

Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations

6Citations
N/AReaders
Get full text

Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: A real-world analysis of a large representative US administrative claims database, 2020–2021

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mehta, P., Gasparyan, A. Y., Zimba, O., Kitas, G. D., & Yessirkepov, M. (2022). Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses. Clinical Rheumatology, 41(12), 3897–3913. https://doi.org/10.1007/s10067-022-06365-y

Readers over time

‘22‘23‘24‘2508162432

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

70%

Professor / Associate Prof. 4

20%

Lecturer / Post doc 1

5%

Researcher 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

41%

Pharmacology, Toxicology and Pharmaceut... 4

24%

Nursing and Health Professions 4

24%

Social Sciences 2

12%

Save time finding and organizing research with Mendeley

Sign up for free
0